Robert Azelby, Director of Tango Therapeutics TNGX, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/19.

RA

RA

Robert Azelby

Director

Company

Tango Therapeutics TNGX

First filing

23/04/12

Trades

19 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/19

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ADC TherapeuticsADCT	Open-market sale	24/06/17	24/06/18	6,995 sh	$2.89	$20,215.55	−11.7%